Active, Not Recruiting Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. NCT03983954 Conditions Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more Locations Shalby Hospital — Ahmedabad, Gujarat, India National Cancer Institute — Jhajjar, Haryana, India All India Institute of Medical Sciences — New Delhi, India PMCH (Pacific Medical College & Hospital) — Udaipur, Rajasthan, India View more locations Show fewer locations Loading locations... View Trial Details
